Introduction (00:00) Prof. Myra Hunter (04:15) Prof. Gary Elkins (34:00) Q&A (01:00:30 ..read more

Anastrozole is often used for 5 years to minimize the risk of developing breast cancer due to a family history. Anastrozole works by lowering the quantity of oestrogen produced in the body. It belongs to a class of medications known as aromatase inhibitors. Some breast cancers rely on oestrogen in the body to flourish. These are known as oestrogen receptor positive (ER-positive) breast cancers. It is used to treat breast cancer in premenopausal women who have had their ovaries... Read more ..read more

A recent article from the Menopause journal discusses the implications of continuing menopausal hormone therapy (HT) beyond the age of 65. It specifically examines the health outcomes associated with the use of estrogen monotherapy in older women. The study highlights significant reductions in risks for several major health issues when estrogen monotherapy is used beyond age 65 compared to discontinuing or never using HT. These health benefits include a 19% reduction in overall... Read more ..read more

First testosterone patch for menopausal women to begin clinical trials this year UK study will look at patch’s effect on boosting libido associated with hormone level drop, which could transform lives globally www.theguardian.com ..read more

Preliminary results of clinical study of Medherant’s testosterone patch for post-menopausal women Medherant’s testosterone TEPI Patch has been well-tolerated and has demonstrated excellent wearability. Medherant is planning for further clinical evaluation of the testosterone TEPI Patch that is being developed for treatment of hypoactive sexual desire disorder, or distressing low libido, in... www.medherant.co.uk 10 April 2024 (Coventry, UK). Medherant is pleased to announce the preliminary results of the Phase I study of its testosterone patch technology being conducted at Hammersmith Med ..read more

Medherant transdermal patch development collaboration with Bayer Coventry, UK (25 March 2024): Medherant Limited (“Medherant”) announces that it has entered into a Development Collaboration Agreement with Bayer for the development of a transdermal patch product for delivery of an already-approved oral medicine. For the last 3 years, Medherant and Bayer have... www.medherant.co.uk Coventry, UK (25 March 2024): Medherant Limited (“Medherant”) announces that it has entered into a Development Collaboration Agreement with Bayer for the development of a transdermal patch product for delivery of ..read more

Dr. Harper and I discuss the importance of testosterone for women’s health, including muscle mass, metabolism, mental health, and the health of the genitourinary tract. We address common questions and misconceptions about testosterone, such as why it isn’t easy to prescribe and the normal ranges for women. We also explore the use of testosterone in the treatment of genetic urinary syndrome of menopause and its potential benefits for breast cancer survivors... Read more ..read more

How to pick the right local estrogen for genitourinary syndrome of menopause // There are many ways to safely treat vaginal dryness, now called genitourinary syndrome of menopause. The safest and most effective treatment for vaginal dryness during and after menopause is vaginal estrogen. In this video, I walk you through how I help my patients make decisions on which type of vaginal estrogen is the best for them depending on their menopausal symptoms.... Read more ..read more

5 Things You Should Know About Vaginal Estrogen with Dr. Rachel Rubin is the topic in today’s episode of Perimenopause WTF! hosted by Rachel Hughes. Today Rachel speaks with Dr. Rachel Rubin to talk about a topic close to her heart, vaginal estrogen. Listen up as Dr. Rubin offers up a wealth of information, answering the most pressing questions from the perry community, advocating passionately about the benefits of vaginal estrogen, sexual health and so much... Read more ..read more

This week we mark 250 episodes of the Dr Louise Newson Podcast! And joining Dr Louise this week is Anita Nicholson, a nurse practitioner and menopause expert at Age Management Center in the US, where she aims to help patients lead the best quality of life for as long as they can. Here, Dr Louise and Anita compare notes on the attitudes towards testosterone in the UK and the US, share their clinical experience of the benefits it can provide women, particularly... Read more ..read more